RESUMO
BACKGROUND AND AIMS: Current practice on Helicobacter pylori infection mostly focuses on individual-based care in the community, but family-based H. pylori management has recently been suggested as a better strategy for infection control. However, the family-based H. pylori infection status, risk factors and transmission pattern remain to be elucidated. METHODS: From September 2021 to December 2021, 10 735 families (31 098 individuals) were enrolled from 29 of 31 provinces in mainland China to examine family-based H. pylori infection, related factors and transmission pattern. All family members were required to answer questionnaires and test for H. pylori infection. RESULTS: Among all participants, the average individual-based H. pylori infection rate was 40.66%, with 43.45% for adults and 20.55% for children and adolescents. Family-based infection rates ranged from 50.27% to 85.06% among the 29 provinces, with an average rate of 71.21%. In 28.87% (3099/10 735) of enrolled families, there were no infections; the remaining 71.13% (7636/10 735) of families had 1-7 infected members, and in 19.70% (1504/7636), all members were infected. Among 7961 enrolled couples, 33.21% had no infection, but in 22.99%, both were infected. Childhood infection was significantly associated with parental infection. Independent risk factors for household infection were infected family members (eg, five infected members: OR 2.72, 95% CI 1.86 to 4.00), living in highly infected areas (eg, northwest China: OR 1.83, 95% CI 1.57 to 2.13), and large families in a household (eg, family of three: OR 1.97, 95% CI 1.76 to 2.21). However, family members with higher education and income levels (OR 0.85, 95% CI 0.79 to 0.91), using serving spoons or chopsticks, more generations in a household (eg, three generations: OR 0.79, 95% CI 0.68 to 0.92), and who were younger (OR 0.57, 95% CI 0.46 to 0.70) had lower infection rates (p<0.05). CONCLUSION: Familial H. pylori infection rate is high in general household in China. Exposure to infected family members is likely the major source of its spread. These results provide supporting evidence for the strategic changes from H. pylori individual-based treatment to family-based management, and the notion has important clinical and public health implications for infection control and related disease prevention.
Assuntos
Infecções por Helicobacter , Helicobacter pylori , Criança , Adulto , Adolescente , Humanos , Infecções por Helicobacter/epidemiologia , Infecções por Helicobacter/prevenção & controle , Família , Fatores de Risco , China/epidemiologia , Estudos Epidemiológicos , PrevalênciaRESUMO
Objectives: To explore the role of computed tomography (CT) severity index (CTSI) and modified CT severity index (MCTSI) in assessing the severity of acute pancreatitis (AP) under the revised Atlanta classification (RAC) and predicting the clinical prognosis. Methods: Based on the prospectively entered AP database, the clinical data of consecutive adult AP inpatients admitted to the Department of Gastroenterology of the First Affiliated Hospital of Nanchang University from January 2012 to December 2020 were retrospectively screened. The imaging data were independently evaluated by two radiologists and entered to the database to calculate the CTSI and MCTSI scores. Their relationship with the difference of RAC severity grade and clinical prognosis was analyzed. Compared with Acute Physiology and Chronic Health Assessment â ¡ (APACHE â ¡) score, the receiver operating characteristic curve was used to evaluate the predictive value of CTSI and MCTSI scores for persistent organ failure and infectious pancreatic necrosis (IPN). Results: A total of 2 612 patients with AP, aged (50±15) years, were included in the study, including 1 547 males (59.2%) and 1 065 females (40.8%). According to RAC standard, AP was divided into 699 cases (26.8%) of mild pancreatitis (MAP), 1 098 cases (42.0%) of moderately severe pancreatitis (MSAP), and 815 cases (31.2%) of severe pancreatitis (SAP). MCTSI judged AP severity similarly to RAC, with 668 cases of MAP (25.6%), 1 207 cases of MSAP (46.2%) and 737 cases of SAP (28.2%), while CTSI judged SAP patients less(400 cases, 15.3%). The severity of AP determined by CTSI and MCTSI scores was significantly correlated with clinical prognosis (r=0.06-0.43, all P<0.05). Compared with APACHE â ¡ score, CTSI had the highest area under the curve (AUC) for predicting IPN (AUC=0.85, 95%CI: 0.83-0.87), followed by MCTSI (AUC=0.82, 95%CI: 0.80-0.85). APACHE â ¡ was more accurate in predicting persistent organ failure than CTSI and MCTSI scores,with AUC of 0.73 (95%CI: 0.71-0.75), 0.72 (95%CI: 0.70-0.74) and 0.72 (95%CI: 0.70-0.74), respectively. Conclusions: AP severity judged by MCTSI is consistent with RAC, and SAP patients judged by CTSI are less than RAC. CTSI and MCTSI are significantly correlated with clinical prognosis. CTSI and MCTSI have higher accuracy in predicting IPN, but lower accuracy in predicting persistent organ failure than APACHE â ¡.
Assuntos
Pancreatite , Doença Aguda , Adulto , Feminino , Humanos , Masculino , Pancreatite/diagnóstico por imagem , Valor Preditivo dos Testes , Prognóstico , Estudos Retrospectivos , Índice de Gravidade de Doença , Tomografia Computadorizada por Raios XRESUMO
The fifth national consensus conference on the management of Helicobacter pylori (H.pylori) infection organized by Chinese Medical Association, Chinese Society of Gastroenterology, H. pylori and Peptic Ulcer Study Group was held at Hangzhou, Zhejiang Province on December 15-16, 2016.More than 80 members of the study group and experts in the field of H. pylori research and gastroenterology attended the meeting.Consensus preparatory group was established to draft the related statements.The quality of evidence and strength of recommendation were evaluated by GRADE system.The Delphi method using an anonymous electronic system was adopted to develop the consensus of relevant statements.Expert advices about the established statements were firstly consulted through the emails.After two rounds of consultation, the preliminary statements of consensus were discussed and modified in the conference item by item.A total of 21 core members voted for the final version, which contained a total of 48 statements and was divided into 6 parts, including indications for H. pylori eradication, diagnosis, treatment, H. pylori and gastric cancer, H. pylori infection in special populations, H. pylori and gastrointestinal microbiota.
Assuntos
Infecções por Helicobacter , Helicobacter pylori , Guias de Prática Clínica como Assunto , Antibacterianos , China , Consenso , Técnica Delphi , Infecções por Helicobacter/complicações , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/terapia , Humanos , Úlcera Péptica , Sociedades Médicas , Neoplasias GástricasRESUMO
OBJECTIVE: To compare the discrepancy between the new(2012) and the old (1992) Atlanta classification criteria for defining severity, organ failure and local complications in patients with acute pancreatitis (AP). METHODS: Demographic, clinical and laboratory data of 2,305 consecutive AP patients with onset less than 3 days, were collected between January 2005 to December 2013 in the First Affiliated Hospital of Nanchang University. Severity, organ failure and pancreatic local complications were respectively classified by the old Atlanta classification and the new revised Atlanta classification. Multi-factor scoring system and single serum marker were recorded and calculated using the acute pancreatitis database. RESULTS: In 2,305 patients with AP, there were 301 cases (13.1%) diagnosed with acute respiratory failure, 136 cases (5.9%) with shock, 105 cases (4.6%) with acute renal failure, 296 cases (12.8%) with gastrointestinal bleeding, based on the old Atlanta classification criteria. According to the severity, 900 cases (39.0%) were classified as mild acute pancreatitis (MAP), 1,405 cases (61.0%) as severe acute pancreatitis (SAP). However, based on the new Atlanta classification criteria, there were 686 cases (29.8%) with acute respiratory failure, 129 cases (5.6%) with acute renal failure, 107 cases (4.6%) with circulatory failure. Consequently, 998 cases (43.3%) were classified as MAP, 937 cases (40.7%) as moderately severe acute pancreatitis (MSAP), 370 cases (16.1%) as SAP. The incidence of respiratory failure was lower than that of the old standard. In SAP patients by new criteria, the discharge rate in critical condition and mortality were not only higher than those in MSAP patients (17.0% vs 4.1%, 4.1% vs 1.5%, respectively, all P < 0.001), but also higher than those in SAP patients by the old classification (17.0% vs 7.2%, 4.1% vs 2.1%, all P < 0.001). CONCLUSIONS: The diagnostic criteria of organ failure are different between the new and old Atlanta classification. The SAP patients classified by the new standard have worse outcome than those by the old standard. More attention needs to be paid to critical patients stratified by the new standard.
Assuntos
Pancreatite/classificação , Pancreatite/diagnóstico , Doença Aguda , Injúria Renal Aguda/epidemiologia , Biomarcadores/sangue , Hemorragia Gastrointestinal/epidemiologia , Humanos , Incidência , Pâncreas/fisiopatologia , Pancreatite/epidemiologia , Síndrome do Desconforto Respiratório/epidemiologia , Estudos Retrospectivos , Índice de Gravidade de DoençaRESUMO
Kyoto global consensus report on Helicobacter pylori gastritis (Gut, July 2015) is another important international consensus since the European Maastricht â £ consensus was published. Kyoto consensus will improve the etiology-based classification, the diagnostic assessment of gastritis, and the treatment of H. pylori-associated dyspepsia and H. pylori gastritis. However, because of high rate of H. pylori infection and antibiotic resistance as well as limited health resources in China, we need to develop our own strategies of H. pylori infection control with the reference of the Kyoto global consensus.
Assuntos
Dispepsia/terapia , Gastrite/terapia , Infecções por Helicobacter/terapia , China , Consenso , Dispepsia/microbiologia , Gastrite/microbiologia , Helicobacter pylori , HumanosRESUMO
Helicobacter pylori (H. pylori) is a gram-negative pathogen that widely colonizes in the human gastric mucosa, and is associated with various gastric diseases. Recently, much attention has been aroused on the relationship between H. pylori infection and autophagy. Accumulating evidence suggests that H. pylori can induce autophagy in gastric epithelial cells and professional phagocytes. Both the virulent factors of H. pylori and host autophagic proteins have been demonstrated to affect H. pylori-induced autophagy. Besides, the process of autophagy plays an important role in determining the intracellular fate of H. pylori. Here, we review the impact of H. pylori infection on autophagy of different cells.
Assuntos
Autofagia , Infecções por Helicobacter/imunologia , Helicobacter pylori , Interações Hospedeiro-Patógeno , HumanosRESUMO
BACKGROUND: The pharmacokinetic and clinical behaviors of many proton pump inhibitors (PPIs) in peptic ulcer treatment are altered by CYP2C19 genetic polymorphisms. This non-inferiority study evaluated the efficacy and safety of the novel PPI anaprazole compared with rabeprazole. We also explored the influence of Helicobacter pylori ( H. pylori ) infection status and CYP2C19 polymorphism on anaprazole. METHODS: In this multicenter, randomized, double-blind, double-dummy, positive-drug parallel-controlled, phase III study, Chinese patients with duodenal ulcers were randomized 1:1 to receive rabeprazole 10 mg + anaprazole placebo or rabeprazole placebo + anaprazole 20 mg once daily for 4 weeks. The primary efficacy endpoint was the 4-week ulcer healing rate assessed by blinded independent review. Secondary endpoints were the proportion of patients with improved overall and individual duodenal ulcer symptoms at 4 weeks. Furthermore, exploratory subgroup analysis of the primary endpoint by H. pylori status and CYP2C19 polymorphism was conducted. Adverse events were monitored for safety. Non-inferiority analysis was conducted for the primary endpoint. RESULTS: The study enrolled 448 patients (anaprazole, n = 225; rabeprazole, n = 223). The 4-week healing rates were 90.9% and 93.7% for anaprazole and rabeprazole, respectively (difference, -2.8% [95% confidence interval, -7.7%, 2.2%]), demonstrating non-inferiority of anaprazole to rabeprazole. Overall duodenal ulcer symptoms improved in 90.9% and 92.5% of patients, respectively. Improvement rates of individual symptoms were similar between the groups. Healing rates did not significantly differ by H. pylori status or CYP2C19 genotype for either treatment group. The incidence of treatment-emergent adverse events was similar for anaprazole (72/220, 32.7%) and rabeprazole (84/219, 38.4%). CONCLUSIONS: The efficacy of anaprazole is non-inferior to that of rabeprazole in Chinese patients with duodenal ulcers. REGISTRATION: ClinicalTrials.gov, NCT04215653.
Assuntos
Antiulcerosos , Úlcera Duodenal , Infecções por Helicobacter , Helicobacter pylori , Humanos , Rabeprazol/uso terapêutico , Úlcera Duodenal/tratamento farmacológico , Úlcera Duodenal/complicações , Citocromo P-450 CYP2C19/genética , Omeprazol/uso terapêutico , Antiulcerosos/uso terapêutico , Amoxicilina , Inibidores da Bomba de Prótons/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Quimioterapia CombinadaRESUMO
Helicobacter pylori (H. pylori) infection is associated with various gastric and extra-gastric diseases. Importantly, this infection is the strongest known risk factor for gastric cancer (GC). H. pylori eradication can effectively prevent H. pylori infection-associated diseases in H. pylori-positive patients, including children and elderly subjects. However, a limited selection of antibiotics, a higher reinfection rate, and certain spontaneous clearance rates, to some extent, restrict the choice of H. pylori treatments in pediatrics. In addition, it is imperative to perform an accurate diagnosis of H. pylori infection in children by determining the presence of the H. pylori infection and the underlying cause of symptoms. In elderly patients, poor tolerance to drugs and higher sensitivity to adverse effects are major concerns during H. pylori therapy. Recent studies have demonstrated that H. pylori eradication could significantly lower the GC risk in the elderly population. The benefit and risk of H. pylori eradication in elderly patients should be comprehensively considered and balanced. If available, susceptibility-based tailored therapies may be preferable in eradicating H. pylori. In addition, to increase the eradication rate and reduce adverse effects, new therapeutic strategies (e.g., probiotic supplementation, berberine supplementation, dual therapy) for H. pylori infection are being extensively investigated. The impact of H. pylori eradication with antibiotics on the microbiota in children has been explored, but further high-quality studies are crucial to delineate the extent of H. pylori eradication affecting the microbial community in children. In this review, we summarize the current understanding of H. pylori diagnosis and treatment in children and the elderly population and aim to provide insights into the efficient management and treatment implementation in these populations.